Swiss - Delayed Quote CHF

Newron Pharmaceuticals S.p.A. (NWRN.SW)

Compare
8.85 -0.13 (-1.45%)
As of 5:07 PM GMT+2. Market Open.

Research Analysis

Revenue vs. Earnings

Revenue 1.7M
Earnings -4.78M
?

Analyst Price Targets

13.66
14.34 Average
8.85 Current
15.01 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts ----33
Avg. Estimate 000.040.07
Low Estimate 00-0.89-0.91
High Estimate 001.131.15
Year Ago EPS -----0.880.04

Revenue Estimate

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
No. of Analysts ----33
Avg. Estimate ----21.71M22.74M
Low Estimate ----7.07M7.14M
High Estimate ----34.49M34.87M
Year Ago Sales ----8.77M21.71M
Sales Growth (year/est) ----147.40%4.70%

Earnings History

CURRENCY IN USD
EPS Est. --
EPS Actual --
Difference --
Surprise % --

EPS Trend

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Current Estimate 000.040.07
7 Days Ago 000.040.07
30 Days Ago 000.040.07
60 Days Ago 000.040.07
90 Days Ago 000-0.02

EPS Revisions

CURRENCY IN USD Current Qtr. (Jun 2024)Next Qtr. (Sep 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD NWRN.SWIndustrySectorS&P 500
Current Qtr. ------3.60%
Next Qtr. ------7.90%
Current Year 104.50%----2.50%
Next Year 75.00%----13.10%
Next 5 Years (per annum) ------11.87%
Past 5 Years (per annum) --------

Related Tickers